Last updated: 12 October 2023 at 7:42pm EST

Dr. Richard G. Ghalie Net Worth



Dr. Richard G. Ghalie biography

Dr. Richard G. Ghalie is the Chief Medical Officer at MEI Pharma Inc.

What is the salary of Dr Ghalie?

As the Chief Medical Officer of MEI Pharma Inc, the total compensation of Dr Ghalie at MEI Pharma Inc is $550,546. There are 7 executives at MEI Pharma Inc getting paid more, with Daniel Gold having the highest compensation of $1,854,410.



How old is Dr Ghalie?

Dr Ghalie is 63, he's been the Chief Medical Officer of MEI Pharma Inc since . There are 7 older and 8 younger executives at MEI Pharma Inc. The oldest executive at MEI Pharma Inc is Kevan Clemens, 75, who is the Independent Director.

What's Dr Ghalie's mailing address?

Richard's mailing address filed with the SEC is C/O MEI PHARMA, INC., 11455 EL CAMINO REAL, SUITE 250, SAN DIEGO, CA, 92130.

Insiders trading at MEI Pharma Inc

Over the last 12 years, insiders at MEI Pharma Inc have traded over $26,282,680 worth of MEI Pharma Inc stock and bought 597,450 units worth $2,541,200 . The most active insiders traders include Ventures Vii, Llc Vivo Vent..., Leaf Ventures Ii, L.P.New L..., and Josiah T Austin. On average, MEI Pharma Inc executives and independent directors trade stock every 91 days with the average trade being worth of $360,383. The most recent stock trade was executed by Funds Management Lp Anson A... on 22 September 2023, trading 48,060 units of MEIP stock currently worth $329,211.



What does MEI Pharma Inc do?

mei pharma (nasdaq: meip) is a san diego-based oncology company focused on the clinical development of novel therapies for cancer. our lead drug candidate is pracinostat, a potential best-in-class, oral hdac inhibitor that has been granted breakthrough therapy designation from the fda in combination with azacitidine for the treatment of patients with newly diagnosed aml who are ≥75 years of age or unfit for intensive chemotherapy. our pipeline of drug candidates also includes me-401 (formerly pwt143), a next-generation oral pi3k delta inhibitor, and me-344, a novel mitochondrial inhibitor. for more, please go to www.meipharma.com.



What does MEI Pharma Inc's logo look like?

MEI Pharma Inc logo

MEI Pharma Inc executives and stock owners

MEI Pharma Inc executives and other stock owners filed with the SEC include: